Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines
One measurement of tuberculosis vaccine efficacy in clinical trials is prevention of disease, but different mechanisms can underlie disease prevention. Here, the authors develop a mathematical model that allows to identify mechanisms of action of a vaccine preventing TB disease.
Guardado en:
Autores principales: | Mario Tovar, Sergio Arregui, Dessislava Marinova, Carlos Martín, Joaquín Sanz, Yamir Moreno |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7f1b051f94340bf8236bcac2684bf3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The transcriptional regulatory network of Mycobacterium tuberculosis.
por: Joaquín Sanz, et al.
Publicado: (2011) -
Insulators for 2D nanoelectronics: the gap to bridge
por: Yury Yu. Illarionov, et al.
Publicado: (2020) -
Bridging the Gap in a Rare Cause of Angina
por: Sumanth Khadke, et al.
Publicado: (2021) -
Bridging the Gap: Greater Usability for TEI encoding
por: Stefan Dumont, et al.
Publicado: (2015) -
A multiscale approach for bridging the gap between potency, efficacy, and safety of small molecules directed at membrane proteins
por: Rodrigo Aguayo-Ortiz, et al.
Publicado: (2021)